ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
63 040,02
6,63%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ProQR Therapeutics NV (PRQR)

  7. ProQR Therapeutics NV (PRQR) Actualités

PRQR

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRQR
DateHeureSourceTitreSymboleSociété
15/02/202413h46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
14/02/202412h08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
14/09/202323h20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
16/05/202313h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
25/04/202312h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
24/04/202322h31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
29/03/202322h55Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
29/03/202322h54Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
29/03/202322h08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
14/02/202316h14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
10/11/202212h35TipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
09/11/202221h40TipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
12/08/202203h15TipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
11/08/202214h37TipRanksProQR (PRQR) was downgraded to a Hold Rating at JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
05/08/202212h38TipRanksH.C. Wainwright Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
05/08/202200h35TipRanksChardan Capital Reaffirms Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
04/08/202223h25TipRanksJMP Securities Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
09/05/202204h35TipRanksProQR (PRQR) Gets a Hold Rating from Stifel NicolausNASDAQ:PRQRProQR Therapeutics NV
06/05/202213h46TipRanksChardan Capital Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
06/05/202206h55TipRanksJMP Securities Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202213h25TipRanksChardan Capital Remains a Buy on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202206h25TipRanksJMP Securities Reiterates Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
09/02/202216h27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRQRProQR Therapeutics NV
04/02/202215h13Edgar (US Regulatory)Schedule 13gNASDAQ:PRQRProQR Therapeutics NV
20/01/202206h25TipRanksJMP Securities Keeps Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
16/12/202122h15TipRanksProQR (PRQR) Gets a Buy Rating from JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
09/09/202117h20Dow Jones NewsProQR Therapeutics Shares Rise 29% After Research Deal With LillyNASDAQ:PRQRProQR Therapeutics NV
26/03/202117h33TipRanksAnalyst Lights Up Over ProQR Blindness Trial ResultsNASDAQ:PRQRProQR Therapeutics NV
21/01/202116h34TipRanks2 “Strong Buy” Penny Stocks That Could See Outsized GainsNASDAQ:PRQRProQR Therapeutics NV
06/08/202022h34Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRQRProQR Therapeutics NV
 Showing the most relevant articles for your search:NASDAQ:PRQR

Dernières Valeurs Consultées

EU
CS
Axa
EU
DG
Vinci
EU
RI
Pernod Ricard
EU
ACA
Credit Agricole
EU
HO
Thales
EU
BN
Danone
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
EU
MC
Lvmh Moet Hennessy Louis...
EU
CAP
Capgemini
EU
SGO
Cie de SaintGobain
EU
PX4
SBF 120
COIN
BTCUSD
Bitcoin
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés